| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 2.0 | 0.8 |
| Gross profit | 1.8 | 0.7 |
| Net income | -6.5 | -2.1 |
| EPS (diluted, $ a share) | $-0.52 | $-0.24 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +149.9% |
|---|---|
| Gross margin | 86.6% |
| Operating margin | -324.4% |
10-Q filed with the SEC, NYSE: NRXS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Neuraxis, INC: key numbers
- Share price
- $4.80Close, Nov 16
- Market cap
- $68.1M
- Shares outstanding
- 14.19MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Electromedical & Electrotherapeutic ApparatusSIC 3845
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Neuraxis, INC
All →Neuraxis Dividend
Neuraxis, Inc. declared a third quarter 2026 stock dividend for its Series B Preferred Stock, payable in approximately 81,339 shares of common stock. The dividend is payable on October 30, 2026, to holders of record as of October 26, 2026, with the share count calculated based on a price of $2.38 per share.
- Term
- Q3 2026